Tag Archives: Europe

Regulator Move Re-Opens Arguments over European Transparency

By Julian Upton | Published: March 9, 2011
At the end of last month, European public health and transparency campaigners sent a letter to EC health commissioner John Dalli, outlining their concerns about former EMA head Thomas Lönngren’s recent career move. The Alliance for Lobbying Transparency and Ethics Regulation (ALTER-EU), Health Action International (HAI) Europe, the International Society of Drug Bulletins (ISDB) — and [...]
Posted in Europe, Global, Regulatory | Also tagged , , , , | Leave a comment

Is Hungary Hungry Enough for Pharma?

By Guest Blogger | Published: January 26, 2011
Hungary has taken over the chair of the EU Council, but European pharma is unlikely to gain much from its surface enthusiam, writes Reflector. A new, young, and supposedly business-friendly democracy has swung into European action this month. Hungary, one of the most recent countries to join the European Union, took over the chair of the [...]
Posted in Europe, Global, Guest Blog, Regulatory, Strategy | Also tagged , , , | Leave a comment

Compliance and Disclosure Risks on Anti-Competitive Promotional Spend: Is EuroLand Set to Follow the US?

By William Looney | Published: November 24, 2010
New Cegedim survey documents whether European industry is ready for the challenge. Making sense of the promotional spend and anti-corruption compliance burden is emerging as a key strategic issue for pharma — not just in the US but in the global market space as well, where regulatory safeguards are still porous. New survey research just published [...]
Posted in Global, Legal, Regulatory, compliance | Also tagged , , , , | 1 Comment

NICE News or Bad News?

By William Looney | Published: November 3, 2010
Far from losing its mojo, the UK’s National Institute for Health and Clinical Excellence (NICE) will simply be sharing the stage with a range of new players under NHS reform — none of whom look supportive of the R&D industry. The big issue for industry in the UK this week is handicapping the future of its [...]
Posted in Europe, Global, Regulatory | Also tagged , , , , , , , | Leave a comment

And What Exactly is a Stakeholder?

By Julian Upton | Published: August 19, 2010
Pharma’s uncritical use of the word ‘stakeholder’ has increased to the point where it can refer to almost anyone connected to the industry. But this can have serious consequences, warns Reflector. Like it or not (and frankly, I don’t), stakeholders are here to stay in European pharmaceutical affairs. Don’t get me wrong. I’ve no objection to [...]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , , , , , , | 1 Comment